Cardiovascular risk factors are associated with impaired endothelium dependent vasodilation and reduced vascular compliance. In this study, the correlation with cardiovascular risk factor score of two common techniques for assessing vascular function was compared. Risk factors and vascular function were evaluated in a study population of 122 people with peripheral arterial disease (PAD) or with risk factors for PAD (73 men and 49 women; mean age 69 years). A risk factor score was determined using Framingham criteria. Vascular compliance was assessed by pulse waveform analysis and simultaneous blood pressure measurement. Flow-mediated vasodilation of the brachial artery was measured using duplex ultrasonography. Participants with a high risk factor score had significantly reduced vascular compliance of large and small vessels. By contrast, the difference in flow-mediated vasodilation between those with a high or low risk factor score did not reach statistical significance. There was a significant negative correlation between vascular compliance and risk factor score. There was a similar trend between flow-mediated vasodilation and risk factor score, but this did not reach statistical significance. A measure of vascular compliance was more significantly correlated with cardiovascular risk factor score than was a measure of flow-mediated vasodilation in the study population. Neither technique provided values that were highly correlated with risk factor burden. Although flow-mediated vasodilation is a preferred research tool for assessing vascular function, technical limitations and biological variability may reduce its clinical application in assessing individual cardiovascular risk.
Introduction
One of the most significant contributions to the prevention and treatment of cardiovascular diseases (CVD) has been the identification of risk factors for development of atherosclerosis. Recent evidence suggests that risk factors may exert their influence on cardiovascular events by altering endothelial function. 1 The endothelium plays a key role in maintaining vascular homeostasis by elaborating a panoply of paracrine factors. Paradigmatic of endothelial vasoprotective factors is nitric oxide, which is also a potent vasodilator. Dysfunction of the synthetic pathway for nitric oxide is characterized by reduced endothelial dependent vasodilation. 2 This impairment serves as a marker for a vasculature that is more susceptible to atherogenesis.
Recent studies have shown that the severity of endothelial vasodilator dysfunction increases with the number of cardiovascular risk factors present in an individual. 3 Additionally, endothelial vasodilator dysfunction is associated with more cardiovascular events and therefore assessment of endothelial function could have prognostic value. 4 Interventions known to reduce cardiovascular events, such as treatment with statins, angiotensin-converting enzyme inhibitors, and dietary interventions, also improve endothelial vasodilator function. 2 Thus, optimizing or maintaining endothelial homeostasis may be a prime target in the prevention and treatment of CVD and, theoretically, assessment of endothelial function could guide the selection of appropriate strategies to reduce cardiovascular risk. However, a first step in this approach to treatment requires a standardized method to assess endothelial function that is reliable and readily available for use.
Flow-mediated vasodilation (FMVD) has long been the accepted standard for measurement of endothelial vasodilator function. However, there is growing, but unpublished, concern in the research community that its research and clinical utility is limited because this costly technology has suboptimal resolution and is susceptible to operator error, and it is not a high throughput technique. Thus, other methods continue to be developed and tested. Noninvasive assessment of vascular compliance using pulse wave contour analysis has emerged as a potential alternative to FMVD. 5 A direct comparison of the two techniques with respect to the correlation of vascular measurements with cardiovascular risk factors has not been performed. Accordingly, this study examined the relationship between vascular function (as assessed by FMVD using ultrasound, or vascular compliance using pulse contour analysis) and global assessment of cardiovascular risk factors using the Framingham risk factor score. 6
Materials and methods

Sample
Participants were recruited between October 2002 and November 2003 from the San Francisco Bay area using a media campaign that included radio and print advertising. The study was approved by Stanford University Institutional Review Board and by the review committee of the General Clinical Research Center of Stanford University. Participants were men or women age 50 years or older with peripheral arterial disease (PAD) or risk factors for PAD. Exclusions were made based on the following criteria: (1) major adverse cardiovascular event in the previous 3 months;
(2) active malignancy or tumor; and (3) inability to provide informed consent.
Vascular function
Vascular function was assessed by measurement of vascular compliance and FMVD. These studies were carried out with the person in a supine position in a quiet room with low illumination to minimize environmental effects on the autonomic nervous system. All studies were conducted in the morning, after a 12-hour fast and with medications withheld for 12 hours. Additionally, all participants were placed on a low nitrate diet for 24 hours preceding the endothelial function tests.
Vascular compliance was measured using the HDI Cardiovascular Profilor ® (model DO 2020; Hypertension Diagnostics, Inc., Minneapolis, MN, USA), which combines noninvasive pulse waveform acquisition with simultaneous blood pressure measurements to determine arterial compliance. 7 The HDI tonometer (a piezoelectric transducer) is positioned over the radial artery at the level of the wrist, and adjusted to obtain the maximal amplitude of the pulse waveform.
Simultaneous measurements of blood pressure are made in the contralateral extremity by oscillometry.
The tonometer sensor array adjusts automatically until it obtains a stable waveform. Once this occurs, an analog tracing of 30 seconds' duration and composed of 200 samples per second is digitized and stored for compliance analyses. A modified Windkessel formula is used to determine capacitive compliance or compliance of the proximal aorta and major branches (C1), and oscillatory compliance of the distal arteries (C2). Thus, C1 is a measure of large vessel compliance, and C2 reflects small vessel compliance and is an indirect measure of endothelial function. The results are expressed as ml/mmHg ϫ 10 (C1) and ml/mmHg ϫ 100 (C2), which represent large and small arterial compliance respectively.
FMVD of the brachial artery was measured using a Siemens Acuson Sequoia C256 high-resolution ultrasound machine (Siemens Medical Solutions USA, Inc., Malvern, PA) using a 14 mHz probe and established techniques. 8 The percentage change in diameter of the brachial artery was assessed at rest and also its status after reactive hyperemia. The probe was placed approximately 4 cm proximal to the antecubital crease at the medial base of the biceps brachi. The near and far intimal layers of the brachial artery were identified. A blood pressure cuff was placed on the forearm below the transducer and inflated to a pressure of 50 mmHg above the patient's systolic pressure for a period of 5 minutes. Measurements of brachial artery diameter were performed 30, 45 and 60 seconds after cuff deflation. Prior studies have shown that the peak blood flow occurs approximately 60 seconds after cuff deflation. 8 Arterial diameter was measured using electronic calipers. FMVD is expressed as a percentage change in vessel diameter from rest to post-reactive hyperemia.
Risk factor score Risk factor assessment was performed using the Framingham guidelines. 6 A risk factor score was calculated for each individual based on these guidelines after taking a careful history and carrying out a physical examination. Risk factor profiles were assigned according to current medication records or by objective measurement of the risk factor. We utilized current definitions for hyperlipidemia, hypertension and diabetes. Dyslipidemia was defined as low-density lipoprotein (LDL)-cholesterol Ͼ100 mg/dl. Hypertension was defined as systolic blood pressure Ͼ140 mmHg, and diastolic blood pressure Ͼ90 mmHg, diabetes mellitus as a fasting serum glucose level Ͼ125 mg/dl. Tobacco use was documented in current smokers or former smokers who had quit within the preceding year. A previous medical history of coronary artery disease, stroke or transient ischemic attack was noted. PAD was diagnosed by physical examination and measurement of the ankle-brachial index (ABI). A diagnosis of PAD was confirmed in patients in whom the ABI was Ͻ0.9.
Statistical analyses
The clinical characteristics of the study sample are reported as means and standard deviations. The Pearson correlation coefficient was used to analyze the associations between endothelial function and cardiovascular risk factor score. The ␣ level for all tests was set at 0.05 using a two-tailed test of significance. To assess the test parameters statistically, Cronbach's alpha test and intraclass correlations (ICC) were used. Cronbach's alpha is a coefficient of reliability (or consistency). The alpha value is higher when there is homogeneity of variances among items. A reliability coefficient of 0.8 or higher is considered acceptable. Intraclass correlation is used to measure inter-rater reliability. Although Pearson's r may be used to assess test-retest reliability, intraclass correlation is preferred when the sample size is small (Ͻ15) or when there are more than two tests (one test, one retest) to be correlated. The value for intraclass correlation will approach 1.0 when there is no variance within targets and all raters give the same ratings.
All analyses to determine the statistical significance of correlations between risk factors and vascular function (vascular compliance or FMVD) were performed using the statistical program SPSS version 12.0 from SPSS Inc., Chicago, IL.
Results
Test parameters
The reproducibility of the vascular studies performed independently by two different technicians is shown in Table 1 . The coefficient of variation for technicians 1 and 2 were 0.22 and 0.24 respectively for C1 measurements and 0.30 and 0.26 for C2 measurements. Similarly, the values obtained for technicians 1 and 2 for FMVD measurements were 0.25 and 0.31 respectively for performance of technique, and 0.37 and 0.31 respectively for measurement of images. Values for the coefficient of variation for each technique were similar to those previously reported in the literature. 7, [9] [10] [11] 
Vascular function in low versus high risk groups
The baseline characteristics of the study population are shown in Table 2 . The 122 participants were people with cardiovascular risk factors as well as those with a diagnosis of PAD. Their mean age was 69 years (73 men aged 54-87 years, mean 70 years; and 49 women aged 55-85 years, mean 67.9 years). A risk factor score was calculated for each individual using the Framingham guidelines. Participants were then divided into low and high risk groups on the basis of their risk factor score. Those considered to be low risk had a global risk score ranging from 0 to 9, whereas scores greater than 10 were considered to be high risk.
Vascular compliance measurements were significantly different between the high and low risk groups (p Ͻ 0.01; Figure 1 ). Large artery compliance in the high risk group was 20.2% lower than in the low risk group. Small artery compliance was 34.3% lower in the high versus the low risk group. These percentages represent the difference in absolute values between the two groups. By contrast, the difference between high and low risk groups in FMVD did not attain statistical significance. 
Vascular function and global cardiovascular risk score
There was a weak correlation between global cardiovascular risk factor score and small (C2, p ϭ 0.002) and large (C1, p ϭ 0.011) artery compliance ( Figures  2A and B) . The correlation between FMVD and global risk factor score failed to reach significance ( Figure 2C ).
Vascular function and blood pressure
There was a moderate to strong association between blood pressure (systolic p Ͻ 0.001, diastolic p ϭ 0.01) and pulse pressure (systolic minus diastolic blood pressure, p Ͻ 0.001) measurements and large artery compliance. The associations were modest for small artery compliance and systolic (p Ͻ 0.001), diastolic (p ϭ 0.007) and pulse pressure ( p ϭ 0.002). However, the correlation of blood pressure with compliance is not surprising, given that mean arterial pressure contributes to the calculation of compliance. Blood pressure did not correlate with FMVD (Table 3) .
Vascular function and lipids
Greater large artery compliance was weakly associated with lower total cholesterol (Figure 3 ), high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C). This association was not observed for small artery compliance or FMVD (Table 4 ).
Discussion
Measures of vascular function have been used to assess the response to cardiovascular interventions, The Framingham risk score was calculated for each patient, and the groups divided into those at lower or greater risk. Large and small vessel compliance (C1 and C2 respectively) were significantly reduced in the high risk group. FMVD also tended to be reduced in the higher risk group, but this result did not attain statistical significance. and to predict cardiovascular risk. 12 There is a substantial body of data indicating that risk factors impair endothelial vasodilator function and vascular compliance. Our results are concordant with previous studies. However, the current study highlights the deficiencies of contemporary vascular function testing. We found that vascular function as assessed by waveform analysis using the Cardiovascular Profilor has a stronger association with the cardiovascular global risk factor score than does FMVD assessed by duplex ultrasonography. However, it appears that with either technology there is a significant discordance with the Framingham risk score. This may reflect added information provided by the vascular function studies that is not reflected in the Framingham risk score. Alternatively, the discordance may reflect technical limitations as well as biological variability.
Vascular function and global assessment of cardiovascular risk factors
FMVD and vascular compliance measurements were made by one experienced technician for the entire study. Quality control studies carried out in our laboratory revealed operator dependent variations similar to those reported in the literature for the technology we employed (Table 4 ). 7, [9] [10] [11] We observed that vascular function as measured by large and small artery compliance is impaired in individuals with a greater cardiovascular global risk factor score. There was a similar trend for endothelial function as assessed by FMVD, although the difference between the low and high risk groups did not reach statistical significance. The correlations between risk factors and vascular function were weak when measured with either technology. There was a modest correlation between blood pressure and compliance measures. This is not surprising because mean arterial pressure is a component of the calculation of vascular compliance. Indeed, vascular compliance, as well as stroke volume, determines pulse pressure, which is a strong predictor of cardiovascular events and mortality. [13] [14] [15] [16] [17] In the present study, systolic and diastolic blood pressures and pulse pressure were not significantly associated with FMVD. The weak association shown between FMVD and blood pressure is similar to that noted in an earlier study. 18 Of course, this observation does not invalidate previous observations revealing that endothelial vasodilator dysfunction occurs in hypertension and is corrected by antihypertensive therapy. 19 A modest inverse correlation was observed between total cholesterol and large vessel compliance. This association did not exist for small vessel compliance or FMVD. The poor association of total cholesterol with measures of vascular function may be due to the widespread use of statins in our population, which can induce lipid-independent improvements in nitric oxide synthase activity and other pleiotropic effects. 20 It is also possible that the narrow range of lipid levels in the current study precluded the detection of a weak effect of lipids on endothelial function. The counterintuitive observation that lower HDL-C levels were associated with increased large vessel compliance is consistent with an earlier finding by Lehman and colleagues, who assessed vascular compliance using pulse wave velocity. These researchers reported that in a sample of young heterozygous familial hypercholesterolemia patients, low HDL-C levels were associated with greater aortic compliance. 21 The mechanisms responsible for this relationship are not well understood and require further confirmation and investigation. Alternatively, this correlation may be a spurious finding reflecting the inadequacy of current measures of vascular function.
Admittedly, the poor correlation that we observed between FMVD and cardiovascular risk factors may be due to less variance of cardiovascular global risk in our study population. We studied a population that was older, with a significant burden of cardiovascular risk factors and/or established vascular disease. Earlier studies have demonstrated a modest correlation between FMVD and cardiovascular risk factors, including age, male gender, smoking and risk factor score. 22, 23 These studies typically included young healthy individuals as well as those with coronary heart disease or its equivalents. When vascular function is assessed in healthy versus diseased cohorts, clear differences in vascular function emerge. In the present investigation, cardiovascular risk factors and vascular function were analyzed in a study population that included both patients with PAD and people who had risk factors. Thus our study did not include the full range of vascular function examined in other studies. The narrow spectrum of vascular function in an older population probably reduced our ability to observe correlations. However, our study certainly raises questions regarding the utility of vascular function testing in a population with established risk factors or vascular disease.
Deficiencies of ultrasonography for assessing FMVD
Although our study is the first to highlight the deficiencies of current technologies for the assessment of vascular function, similar conclusions can be drawn from a critical analysis of previous studies. The original study of Celermajer and colleagues examined FMVD and its relationship to risk factors in 500 research participants. By multiple stepwise regression analysis, impaired FMVD was shown to be modestly associated with cigarette smoking, older age, male gender and larger vessel size, but not with total cholesterol level, blood pressure or family history. 2 Leeson and coworkers observed a weak relationship between plasma omega-3 fatty acids and brachial FMVD in 326 healthy people. 24 However, this study failed to find any significant relationship between FMVD and standard risk factors. Schnell et al found no relationship between FMVD and LDL-C or triglycerides in 113 participants. 25 Most notably, Benjamin and colleagues examined a large cohort (n ϭ 2883) from the Framingham study. In a multivariate analysis, they found that FMVD was inversely associated with age, systolic blood pressure, body mass index, and smoking, whereas it was positively related to female gender. 14 However, FMVD was not associated with total/HDL-C, glucose level or diabetes in multivariable models. Furthermore, there was a paradoxically inverse association with lipid-lowering medication and a positive relationship to heart rate. There are reasonable explanations for the lack of expected associations in this study. However, the lack of association of FMVD with traditional risk factors, in such a large cohort studied by one of the most respected groups in this field should raise questions about the technology. Other technologies may be more accurate than brachial artery FMVD in assessing systemic alterations in vasodilator function. In one recent study, the vascular responses of healthy controls (n ϭ 24) and people with coronary artery disease were assessed by simultaneous measurements of FMVD as well as by laser Doppler imaging to assess skin blood flow in the contralateral arm in response to reactive hyperemia. Receiver operator curves for sensitivity/specificity analyses indicated that parameters derived from laser Doppler imaging were superior to FMVD for the diagnosis of coronary artery disease with an overall specificity of 91% and a sensitivity of 74%. 26
Deficiencies of waveform analysis for assessing vascular function
The technology used in this study to assess arterial compliance uses a proprietary algorithm to analyze the pulse waveform derived from radial artery applanation tonometry. The recorded waveform closely approximates the waveforms obtained from direct arterial puncture. 27 The technology provides a relatively high throughput analysis of vascular function and is less operator dependent compared with duplex ultrasonography of FMVD. However, the algorithm used in this device for the derivation of vascular compliance has been criticized for some of its underlying assumptions (Windkessel model of the circulation; selective use of the diastolic component of the pressure waveform; and failure fully to incorporate wave reflection or consider differences between end-systolic pressures in the central and peripheral arteries. [28] [29] [30] Other methods of pulse waveform analysis may be employed. Carotid applanation tonometry was used to determine the augmentation index and was compared with risk scores in 216 people with or without a cardiovascular disease. 31 The augmentation index increased significantly with rising risk scores and was significantly correlated to cardiovascular risk.
FMVD and vascular compliance are only indirect reflections of endothelium-dependent vasodilation. Both measurements are influenced by the synthesis and activity of endothelium-derived nitric oxide. 32, 33 Accordingly, it is not surprising that vascular compliance and FMVD have been reported to be weakly correlated. 34 However, FMVD (like vascular compliance) is also affected directly and dynamically by vascular neurotransmission 35, 36 as well as other endothelial functions and visco-elastic properties of the vessel wall.
However, pharmacological provocation combined with pulse waveform analysis may provide a method of more directly assessing vasomotor endothelial function. The administration of beta 2 adrenergic agonists (albuterol or salbutamol) produces reproducible changes in the radial arterial waveform characterized by a reduction in the augmentation index. 37, 38 This effect is inhibited by N G -monomethyl-L-arginine, indicating that the drug-induced reduction in augmentation index is probably mediated by endotheliumderived nitric oxide. Notably, the effect of the beta 2 adrenergic agonists in reducing the augmentation index is blunted in people with hypercholesterolemia or coronary artery disease. 37, 38 
Conclusion
We found that a measure of vascular compliance correlated with cardiovascular risk factors to a greater degree than did measurement of FMVD. However our study reveals poor correlations of both techniques with global risk score. The discordance between risk factors and vascular tests may be a manifestation of incremental information provided by the vascular studies. Alternatively, it may reflect inadequacies in the resolution and reproducibility of the technologies, as well as biological variability. It is our opinion that the latter conclusion is more likely, given the technical limitations, and the indirect nature of noninvasive assessments of vascular function. New technologies are needed for vascular function testing to enhance its application to clinical practice.
